Natco Pharma Shares Owned By Insiders vs. Net Income

NATCOPHARM   1,431  1.00  0.07%   
Based on the key profitability measurements obtained from Natco Pharma's financial statements, Natco Pharma Limited may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Natco Pharma's ability to earn profits and add value for shareholders.
For Natco Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Natco Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Natco Pharma Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Natco Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Natco Pharma Limited over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Natco Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Natco Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Natco Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Natco Pharma Limited Net Income vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Natco Pharma's current stock value. Our valuation model uses many indicators to compare Natco Pharma value to that of its competitors to determine the firm's financial worth.
Natco Pharma Limited is considered to be number one stock in shares owned by insiders category among its peers. It also is considered to be number one stock in net income category among its peers making up about  272,750,491  of Net Income per Shares Owned By Insiders. As of now, Natco Pharma's Net Income is increasing as compared to previous years. Comparative valuation analysis is a catch-all model that can be used if you cannot value Natco Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Natco Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Natco Net Income vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Natco Pharma

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
50.90 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Natco Pharma

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
13.88 B
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Natco Net Income Comparison

Natco Pharma is currently under evaluation in net income category among its peers.

Natco Pharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Natco Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Natco Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Natco Pharma's change in net profit over the period of time. It can combine multiple indicators of Natco Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income1.5 B1.6 B
Operating Income26 B27.3 B
Income Before Tax16.7 B17.6 B
Total Other Income Expense Net-9.2 B-8.8 B
Net Income13.9 B14.6 B
Income Tax Expense2.9 BB
Net Income From Continuing Ops13.9 B14.6 B
Net Income Applicable To Common Shares8.2 B4.4 B
Interest Income166.8 M158.4 M
Net Interest Income-192 M-182.4 M
Change To Netincome-834.3 M-792.6 M

Natco Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Natco Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Natco Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Natco Pharma's important profitability drivers and their relationship over time.

Use Natco Pharma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Natco Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Natco Pharma will appreciate offsetting losses from the drop in the long position's value.

Natco Pharma Pair Trading

Natco Pharma Limited Pair Trading Analysis

The ability to find closely correlated positions to Natco Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Natco Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Natco Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Natco Pharma Limited to buy it.
The correlation of Natco Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Natco Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Natco Pharma Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Natco Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Natco Pharma position

In addition to having Natco Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Energy ETFs Thematic Idea Now

Energy ETFs
Energy ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 92 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Natco Stock

To fully project Natco Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Natco Pharma Limited at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Natco Pharma's income statement, its balance sheet, and the statement of cash flows.
Potential Natco Pharma investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Natco Pharma investors may work on each financial statement separately, they are all related. The changes in Natco Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Natco Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.